Brent Turner - 22 Feb 2023 Form 4 Insider Report for LHC Group, Inc

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Feb 2023, 15:37:29 UTC
Prior SEC filing
22 Nov 2022
Next SEC filing
05 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Maria S. Wiggins, Attorney-in-Fact

Key filing fact

Brent Turner filed Form 4 for LHC Group, Inc on 22 Feb 2023.

Key facts

  • This page summarizes Brent Turner's Form 4 filing for LHC Group, Inc.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Feb 2023, 15:37.

Change

  • Previous filing in this sequence was filed on 22 Nov 2022.
  • Current net transaction value: -$2,414,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LHCG transaction

Common Stock

Disposed to Issuer

Transaction value
$2,414,000
Shares
-14,200
Change %
-100%
Price
$170.00
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Brent Turner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Each share of issuer common stock was cancelled pursuant to the merger agreement between the issuer and UnitedHealth Group Incorporated in exchange for a cash payment equal to $170.00.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .